Roche's Avastin Gets Another Indication Approval

Published: Thursday, January 24th 2013

(Fierce) - Chalk up another big win for Hal Barron and his R&D team extraordinaire at Genentech. The FDA today approved a new indication for Roche's ($RHHBY) cancer drug Avastin.

Comment(s)

Your comments are valuable to us. Thank you.

T-DM1 Survival Rate Wows as Roche Pushes for Megablockbuster Approval

Roche Gets EU Approval for Breast Cancer Drug Perjeta

Roche Wins FDA Approval for Test to Target Lung Cancer

Avastin Snags Another Approval as Blockbuster's Sales Journey On

Roche Gains Blockbuster Backing for Breast Cancer Therapy in Europe